ID   SO2A1_HUMAN             Reviewed;         643 AA.
AC   Q92959; Q86V98; Q8IUN2;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   10-MAY-2017, entry version 144.
DE   RecName: Full=Solute carrier organic anion transporter family member 2A1;
DE   AltName: Full=Prostaglandin transporter;
DE            Short=PGT;
DE   AltName: Full=Solute carrier family 21 member 2;
GN   Name=SLCO2A1; Synonyms=OATP2A1, SLC21A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT THR-396.
RX   PubMed=8787677; DOI=10.1172/JCI118897;
RA   Lu R., Kanai N., Bao Y., Schuster V.L.;
RT   "Cloning, in vitro expression, and tissue distribution of a human
RT   prostaglandin transporter cDNA(hPGT).";
RL   J. Clin. Invest. 98:1142-1149(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-396.
RX   PubMed=9618293; DOI=10.1006/bbrc.1998.8715;
RA   Lu R., Schuster V.L.;
RT   "Molecular cloning of the gene for the human prostaglandin transporter
RT   hPGT: gene organization, promoter activity, and chromosomal
RT   localization.";
RL   Biochem. Biophys. Res. Commun. 246:805-812(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND VARIANT PHOAR2 SER-557.
RX   PubMed=22331663; DOI=10.1002/humu.22042;
RA   Seifert W., Kuhnisch J., Tuysuz B., Specker C., Brouwers A., Horn D.;
RT   "Mutations in the prostaglandin transporter encoding gene SLCO2A1
RT   cause primary hypertrophic osteoarthropathy and isolated digital
RT   clubbing.";
RL   Hum. Mutat. 33:660-664(2012).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7]
RP   VARIANTS PHOAR2 ARG-222 AND GLU-255.
RX   PubMed=22197487; DOI=10.1016/j.ajhg.2011.11.019;
RA   Zhang Z., Xia W., He J., Zhang Z., Ke Y., Yue H., Wang C., Zhang H.,
RA   Gu J., Hu W., Fu W., Hu Y., Li M., Liu Y.;
RT   "Exome sequencing identifies SLCO2A1 mutations as a cause of primary
RT   hypertrophic osteoarthropathy.";
RL   Am. J. Hum. Genet. 90:125-132(2012).
RN   [8]
RP   VARIANTS PHOAR2 PHE-85; HIS-97; ALA-181; ASP-181; LEU-204; ARG-222;
RP   PHE-420 AND GLY-565, VARIANT CYS-445, AND CHARACTERIZATION OF VARIANT
RP   PHOAR2 PHE-420.
RX   PubMed=22553128; DOI=10.1002/humu.22111;
RA   Diggle C.P., Parry D.A., Logan C.V., Laissue P., Rivera C.,
RA   Restrepo C.M., Fonseca D.J., Morgan J.E., Allanore Y., Fontenay M.,
RA   Wipff J., Varret M., Gibault L., Dalantaeva N., Korbonits M., Zhou B.,
RA   Yuan G., Harifi G., Cefle K., Palanduz S., Akoglu H.,
RA   Zwijnenburg P.J., Lichtenbelt K.D., Aubry-Rozier B., Superti-Furga A.,
RA   Dallapiccola B., Accadia M., Brancati F., Sheridan E.G., Taylor G.R.,
RA   Carr I.M., Johnson C.A., Markham A.F., Bonthron D.T.;
RT   "Prostaglandin transporter mutations cause pachydermoperiostosis with
RT   myelofibrosis.";
RL   Hum. Mutat. 33:1175-1181(2012).
RN   [9]
RP   VARIANTS PHOAR2 ARG-255 AND HIS-556.
RX   PubMed=22696055; DOI=10.1038/jid.2012.146;
RA   Busch J., Frank V., Bachmann N., Otsuka A., Oji V., Metze D., Shah K.,
RA   Danda S., Watzer B., Traupe H., Bolz H.J., Kabashima K., Bergmann C.;
RT   "Mutations in the prostaglandin transporter SLCO2A1 cause primary
RT   hypertrophic osteoarthropathy with digital clubbing.";
RL   J. Invest. Dermatol. 132:2473-2476(2012).
CC   -!- FUNCTION: May mediate the release of newly synthesized
CC       prostaglandins from cells, the transepithelial transport of
CC       prostaglandins, and the clearance of prostaglandins from the
CC       circulation. Transports PGD2, as well as PGE1, PGE2 and PGF2A.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Significant expression observed in
CC       ling, kidney, spleen, and heart. {ECO:0000269|PubMed:22331663}.
CC   -!- DISEASE: Hypertrophic osteoarthropathy, primary, autosomal
CC       recessive, 2 (PHOAR2) [MIM:614441]: A disease characterized by
CC       digital clubbing, periostosis, acroosteolysis, painful joint
CC       enlargement, and variable features of pachydermia that include
CC       thickened facial skin and a thickened scalp. Other developmental
CC       anomalies include delayed closure of the cranial sutures and
CC       congenital heart disease. {ECO:0000269|PubMed:22197487,
CC       ECO:0000269|PubMed:22331663, ECO:0000269|PubMed:22553128,
CC       ECO:0000269|PubMed:22696055}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the organo anion transporter (TC 2.A.60)
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Solute carrier organic anion transporter
CC       family, member 2A1 (SLCO2A1); Note=Leiden Open Variation Database
CC       (LOVD);
CC       URL="http://www.lovd.nl/SLCO2A1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U70867; AAC09469.1; -; mRNA.
DR   EMBL; AF056732; AAC62004.1; -; Genomic_DNA.
DR   EMBL; AF056719; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056720; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056721; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056722; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056723; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056724; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056725; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056726; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056727; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056728; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056729; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056730; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; AF056731; AAC62004.1; JOINED; Genomic_DNA.
DR   EMBL; CH471052; EAW79156.1; -; Genomic_DNA.
DR   EMBL; BC041140; AAH41140.2; -; mRNA.
DR   EMBL; BC051347; AAH51347.1; -; mRNA.
DR   CCDS; CCDS3084.1; -.
DR   RefSeq; NP_005621.2; NM_005630.2.
DR   UniGene; Hs.518270; -.
DR   PDB; 3MRR; X-ray; 1.60 A; P=178-187.
DR   PDBsum; 3MRR; -.
DR   ProteinModelPortal; Q92959; -.
DR   SMR; Q92959; -.
DR   IntAct; Q92959; 1.
DR   STRING; 9606.ENSP00000311291; -.
DR   BindingDB; Q92959; -.
DR   ChEMBL; CHEMBL2073703; -.
DR   DrugBank; DB00770; Alprostadil.
DR   DrugBank; DB04557; Arachidonic Acid.
DR   DrugBank; DB01160; Dinoprost Tromethamine.
DR   DrugBank; DB00917; Dinoprostone.
DR   DrugBank; DB00695; Furosemide.
DR   DrugBank; DB03581; Glucose-6-Phosphate.
DR   DrugBank; DB02263; Glyceraldehyde-3-Phosphate.
DR   DrugBank; DB01088; Iloprost.
DR   DrugBank; DB04398; Lactic Acid.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB01819; Phosphoenolpyruvate.
DR   DrugBank; DB00119; Pyruvic acid.
DR   SwissLipids; SLP:000001646; -.
DR   TCDB; 2.A.60.1.19; the organo anion transporter (oat) family.
DR   PhosphoSitePlus; Q92959; -.
DR   BioMuta; SLCO2A1; -.
DR   DMDM; 218511799; -.
DR   EPD; Q92959; -.
DR   PaxDb; Q92959; -.
DR   PeptideAtlas; Q92959; -.
DR   PRIDE; Q92959; -.
DR   Ensembl; ENST00000310926; ENSP00000311291; ENSG00000174640.
DR   GeneID; 6578; -.
DR   KEGG; hsa:6578; -.
DR   UCSC; uc003eqa.4; human.
DR   CTD; 6578; -.
DR   DisGeNET; 6578; -.
DR   GeneCards; SLCO2A1; -.
DR   H-InvDB; HIX0024333; -.
DR   HGNC; HGNC:10955; SLCO2A1.
DR   HPA; HPA013742; -.
DR   MalaCards; SLCO2A1; -.
DR   MIM; 601460; gene.
DR   MIM; 614441; phenotype.
DR   neXtProt; NX_Q92959; -.
DR   OpenTargets; ENSG00000174640; -.
DR   Orphanet; 2796; Pachydermoperiostosis.
DR   PharmGKB; PA35840; -.
DR   eggNOG; KOG3626; Eukaryota.
DR   eggNOG; ENOG410XRSF; LUCA.
DR   GeneTree; ENSGT00760000119014; -.
DR   HOGENOM; HOG000231269; -.
DR   HOVERGEN; HBG108345; -.
DR   InParanoid; Q92959; -.
DR   KO; K14345; -.
DR   OMA; IYLNCSC; -.
DR   OrthoDB; EOG091G08QD; -.
DR   PhylomeDB; Q92959; -.
DR   TreeFam; TF317540; -.
DR   Reactome; R-HSA-879518; Transport of organic anions.
DR   ChiTaRS; SLCO2A1; human.
DR   EvolutionaryTrace; Q92959; -.
DR   GeneWiki; SLCO2A1; -.
DR   GenomeRNAi; 6578; -.
DR   PRO; PR:Q92959; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000174640; -.
DR   CleanEx; HS_SLCO2A1; -.
DR   ExpressionAtlas; Q92959; baseline and differential.
DR   Genevisible; Q92959; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005319; F:lipid transporter activity; TAS:ProtInc.
DR   GO; GO:0015132; F:prostaglandin transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0006869; P:lipid transport; TAS:ProtInc.
DR   GO; GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR004156; OA_transporter.
DR   PANTHER; PTHR11388; PTHR11388; 1.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF03137; OATP; 1.
DR   SUPFAM; SSF100895; SSF100895; 1.
DR   SUPFAM; SSF103473; SSF103473; 4.
DR   TIGRFAMs; TIGR00805; oat; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Disease mutation;
KW   Disulfide bond; Glycoprotein; Membrane; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    643       Solute carrier organic anion transporter
FT                                family member 2A1.
FT                                /FTId=PRO_0000191058.
FT   TOPO_DOM      1     32       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     33     52       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     53     71       Extracellular. {ECO:0000255}.
FT   TRANSMEM     72     92       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM     93     98       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     99    123       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    124    167       Extracellular. {ECO:0000255}.
FT   TRANSMEM    168    196       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    197    215       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    216    236       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    237    254       Extracellular. {ECO:0000255}.
FT   TRANSMEM    255    279       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    280    321       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    322    343       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    344    363       Extracellular. {ECO:0000255}.
FT   TRANSMEM    364    387       Helical; Name=8. {ECO:0000255}.
FT   TOPO_DOM    388    391       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    392    415       Helical; Name=9. {ECO:0000255}.
FT   TOPO_DOM    416    518       Extracellular. {ECO:0000255}.
FT   TRANSMEM    519    541       Helical; Name=10. {ECO:0000255}.
FT   TOPO_DOM    542    550       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    551    576       Helical; Name=11. {ECO:0000255}.
FT   TOPO_DOM    577    610       Extracellular. {ECO:0000255}.
FT   TRANSMEM    611    629       Helical; Name=12. {ECO:0000255}.
FT   TOPO_DOM    630    643       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      438    496       Kazal-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00798}.
FT   CARBOHYD    134    134       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    478    478       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    491    491       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    444    470       {ECO:0000255|PROSITE-ProRule:PRU00798}.
FT   DISULFID    448    459       {ECO:0000255|PROSITE-ProRule:PRU00798}.
FT   DISULFID    450    474       {ECO:0000255|PROSITE-ProRule:PRU00798}.
FT   VARIANT      85     85       I -> F (in PHOAR2; dbSNP:rs387907296).
FT                                {ECO:0000269|PubMed:22553128}.
FT                                /FTId=VAR_068636.
FT   VARIANT      97     97       R -> H (in PHOAR2).
FT                                {ECO:0000269|PubMed:22553128}.
FT                                /FTId=VAR_068637.
FT   VARIANT     181    181       G -> A (in PHOAR2).
FT                                {ECO:0000269|PubMed:22553128}.
FT                                /FTId=VAR_068638.
FT   VARIANT     181    181       G -> D (in PHOAR2).
FT                                {ECO:0000269|PubMed:22553128}.
FT                                /FTId=VAR_068639.
FT   VARIANT     204    204       S -> L (in PHOAR2; dbSNP:rs555934769).
FT                                {ECO:0000269|PubMed:22553128}.
FT                                /FTId=VAR_068640.
FT   VARIANT     222    222       G -> R (in PHOAR2; dbSNP:rs774795340).
FT                                {ECO:0000269|PubMed:22197487,
FT                                ECO:0000269|PubMed:22553128}.
FT                                /FTId=VAR_067598.
FT   VARIANT     255    255       G -> E (in PHOAR2; dbSNP:rs387906806).
FT                                {ECO:0000269|PubMed:22197487}.
FT                                /FTId=VAR_067599.
FT   VARIANT     255    255       G -> R (in PHOAR2).
FT                                {ECO:0000269|PubMed:22696055}.
FT                                /FTId=VAR_068641.
FT   VARIANT     396    396       A -> T (in dbSNP:rs34550074).
FT                                {ECO:0000269|PubMed:8787677,
FT                                ECO:0000269|PubMed:9618293}.
FT                                /FTId=VAR_053674.
FT   VARIANT     420    420       C -> F (in PHOAR2; reduced activity;
FT                                dbSNP:rs387907295).
FT                                {ECO:0000269|PubMed:22553128}.
FT                                /FTId=VAR_068642.
FT   VARIANT     445    445       R -> C (in dbSNP:rs146970901).
FT                                {ECO:0000269|PubMed:22553128}.
FT                                /FTId=VAR_068643.
FT   VARIANT     556    556       Q -> H (in PHOAR2).
FT                                {ECO:0000269|PubMed:22696055}.
FT                                /FTId=VAR_068644.
FT   VARIANT     557    557       F -> S (in PHOAR2).
FT                                {ECO:0000269|PubMed:22331663}.
FT                                /FTId=VAR_068352.
FT   VARIANT     565    565       W -> G (in PHOAR2).
FT                                {ECO:0000269|PubMed:22553128}.
FT                                /FTId=VAR_068645.
FT   CONFLICT      9      9       A -> V (in Ref. 1; AAC09469 and 2;
FT                                AAC62004). {ECO:0000305}.
FT   CONFLICT    228    228       V -> I (in Ref. 1; AAC09469 and 2;
FT                                AAC62004). {ECO:0000305}.
FT   STRAND      181    183       {ECO:0000244|PDB:3MRR}.
SQ   SEQUENCE   643 AA;  70044 MW;  A1FF933246480984 CRC64;
     MGLLPKLGAS QGSDTSTSRA GRCARSVFGN IKVFVLCQGL LQLCQLLYSA YFKSSLTTIE
     KRFGLSSSSS GLISSLNEIS NAILIIFVSY FGSRVHRPRL IGIGGLFLAA GAFILTLPHF
     LSEPYQYTLA STGNNSRLQA ELCQKHWQDL PPSKCHSTTQ NPQKETSSMW GLMVVAQLLA
     GIGTVPIQPF GISYVDDFSE PSNSPLYISI LFAISVFGPA FGYLLGSVML QIFVDYGRVN
     TAAVNLVPGD PRWIGAWWLG LLISSALLVL TSFPFFFFPR AMPIGAKRAP ATADEARKLE
     EAKSRGSLVD FIKRFPCIFL RLLMNSLFVL VVLAQCTFSS VIAGLSTFLN KFLEKQYGTS
     AAYANFLIGA VNLPAAALGM LFGGILMKRF VFSLQAIPRI ATTIITISMI LCVPLFFMGC
     STPTVAEVYP PSTSSSIHPQ SPACRRDCSC PDSIFHPVCG DNGIEYLSPC HAGCSNINMS
     SATSKQLIYL NCSCVTGGSA SAKTGSCPVP CAHFLLPAIF LISFVSLIAC ISHNPLYMMV
     LRVVNQEEKS FAIGVQFLLM RLLAWLPSPA LYGLTIDHSC IRWNSLCLGR RGACAYYDND
     ALRDRYLGLQ MGYKALGMLL LCFISWRVKK NKEYNVQKAA GLI
//
